Patents Assigned to Arne Forsgren AB
  • Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system
    Patent number: 10786562
    Abstract: The present disclosure relates to surface proteins of Moraxella catarrhalis and their ability to interact with epithelial cells via cell-associated fibronectin and laminin, and also to their ability to inhibit the complement system. These surface proteins are useful in the preparation of vaccines. The present disclosure also provides peptides interacting with fibronectin, laminin and the complement system.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: September 29, 2020
    Assignee: ARNE FORSGREN AB
    Inventors: Arne Forsgren, Kristian Riesbeck
  • INTERACTION OF MORAXELLA CATARRHALIS WITH EPITHELIAL CELLS, EXTRACELLULAR MATRIX PROTEINS AND THE COMPLEMENT SYSTEM
    Publication number: 20190117757
    Abstract: The present disclosure relates to surface proteins of Moraxella catarrhalis and their ability to interact with epithelial cells via cell-associated fibronectin and laminin, and also to their ability to inhibit the complement system. These surface proteins are useful in the preparation of vaccines. The present disclosure also provides peptides interacting with fibronectin, laminin and the complement system.
    Type: Application
    Filed: December 18, 2018
    Publication date: April 25, 2019
    Applicant: ARNE FORSGREN AB
    Inventors: Arne FORSGREN, Kristian RIESBECK
  • Interaction of moraxella catarrhalis with epithellal cells, extracellular matrix proteins and the complement system
    Patent number: 10183071
    Abstract: The present disclosure relates to surface proteins of Moraxella catarrhalis and their ability to interact with epithelial cells via cell-associated fibronectin and laminin, and also to their ability to inhibit the complement system. These surface proteins are useful in the preparation of vaccines. The present disclosure also provides peptides interacting with fibronectin, laminin and the complement system.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: January 22, 2019
    Assignee: ARNE FORSGREN AB
    Inventors: Arne Forsgren, Kristian Riesbeck
  • INTERACTION OF MORAXELLA CATARRHALIS WITH EPITHELLAL CELLS, EXTRACELLULAR MATRIX PROTEINS AND THE COMPLEMENT SYSTEM
    Publication number: 20170281746
    Abstract: The present disclosure relates to surface proteins of Moraxella catarrhalis and their ability to interact with epithelial cells via cell-associated fibronectin and laminin, and also to their ability to inhibit the complement system. These surface proteins are useful in the preparation of vaccines. The present disclosure also provides peptides interacting with fibronectin, laminin and the complement system.
    Type: Application
    Filed: April 13, 2017
    Publication date: October 5, 2017
    Applicant: ARNE FORSGREN AB
    Inventors: Arne FORSGREN, Kristian RIESBECK
  • Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system
    Patent number: 9657067
    Abstract: The present disclosure relates to surface proteins of Moraxella catarrhalis and their ability to interact with epithelial cells via cell-associated fibronectin and laminin, and also to their ability to inhibit the complement system. These surface proteins are useful in the preparation of vaccines. The present disclosure also provides peptides interacting with fibronectin, laminin and the complement system.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: May 23, 2017
    Assignee: ARNE FORSGREN AB
    Inventors: Arne Forsgren, Kristian Riesbeck
  • INTERACTION OF MORAXELLA CATARRHALIS WITH EPITHELIAL CELLS, EXTRACELLULAR MATRIX PROTEINS AND THE COMPLEMENT SYSTEM
    Publication number: 20160318979
    Abstract: The present disclosure relates to surface proteins of Moraxella catarrhalis and their ability to interact with epithelial cells via cell-associated fibronectin and laminin, and also to their ability to inhibit the complement system. These surface proteins are useful in the preparation of vaccines. The present disclosure also provides peptides interacting with fibronectin, laminin and the complement system.
    Type: Application
    Filed: December 31, 2015
    Publication date: November 3, 2016
    Applicant: ARNE FORSGREN AB
    Inventors: ARNE FORSGREN, KRISTIAN RIESBECK
  • Interaction of with epithelial cells, extracellular matrix proteins and the complement system
    Patent number: 9255127
    Abstract: The present disclosure relates to surface proteins of Moraxella catarrhalis and their ability to interact with epithelial cells via cell-associated fibronectin and laminin, and also to their ability to inhibit the complement system. These surface proteins are useful in the preparation of vaccines. The present disclosure also provides peptides interacting with fibronectin, laminin and the complement system.
    Type: Grant
    Filed: October 7, 2014
    Date of Patent: February 9, 2016
    Assignee: Arne Forsgren AB
    Inventors: Olle Forsgren, Kristian Riesbeck
  • INTERACTION OF MORAXELLA CATARRHALIS WITH EPITHELIAL CELLS, EXTRACELLULAR MATRIX PROTEINS AND THE COMPLEMENT SYSTEM
    Publication number: 20150140026
    Abstract: The present disclosure relates to surface proteins of Moraxella catarrhalis and their ability to interact with epithelial cells via cell-associated fibronectin and laminin, and also to their ability to inhibit the complement system. These surface proteins are useful in the preparation of vaccines. The present disclosure also provides peptides interacting with fibronectin, laminin and the complement system.
    Type: Application
    Filed: October 7, 2014
    Publication date: May 21, 2015
    Applicant: ARNE FORSGREN AB
    Inventors: ARNE FORSGREN, KRISTIAN RIESBECK
  • Interaction of with epithelial cells, extracellular matrix proteins and the complement system
    Patent number: 8895030
    Abstract: The present disclosure relates to surface proteins of Moraxella catarrhalis and their ability to interact with epithelial cells via cell-associated fibronectin and laminin, and also to their ability to inhibit the complement system. These surface proteins are useful in the preparation of vaccines. The present disclosure also provides peptides interacting with fibronectin, laminin and the complement system.
    Type: Grant
    Filed: November 1, 2012
    Date of Patent: November 25, 2014
    Assignee: Arne Forsgren AB
    Inventors: Arne Forsgren, Kristian Riesbeck
  • Interaction of with epithelial cells, extracellular matrix proteins and the complement system
    Patent number: 8323667
    Abstract: The present disclosure relates to surface proteins of Moraxella catarrhalis and their ability to interact with epithelial cells via cell-associated fibronectin and laminin, and also to their ability to inhibit the complement system. These surface proteins are useful in the preparation of vaccines. The present disclosure also provides peptides interacting with fibronectin, laminin and the complement system.
    Type: Grant
    Filed: December 8, 2011
    Date of Patent: December 4, 2012
    Assignee: Arne Forsgren AB
    Inventors: Arne Forsgren, Kristian Riesbeck
  • Interaction of with epithelial cells, extracellular matrix proteins and the complement system
    Patent number: 8092811
    Abstract: The present invention relates to surface proteins of Moraxella catarrhalis and their ability to interact with epithelial cells via cell-associated fibronectin and laminin, and also to their ability to inhibit the complement system. These surface proteins are useful in the preparation of vaccines. The present invention also provides peptides interacting with fibronectin, laminin and the complement system.
    Type: Grant
    Filed: August 8, 2006
    Date of Patent: January 10, 2012
    Assignee: Arne Forsgren AB
    Inventors: Arne Forsgren, Kristian Riesbeck